Daniel Marovitz

CEO F1000 (United Kingdom)

photo_of_daniel_copyDaniel identified a lack of constructive communication between pharma and health care companies, initially inspiring him to develop F1000, a platform that powers professional conversation and discussion between researchers. Today, the platform is one of the biggest open source publication sites and now allows for researchers across a number of teams to share, tag, and analyze information.